Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology
Open Access
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 7 (6), 427-434
- https://doi.org/10.1186/cc2337
Abstract
Vasopressin is emerging as a rational therapy for vasodilatory shock states. Unlike other vasoconstrictor agents, vasopressin also has vasodilatory properties. The goal of the present review is to explore the vascular actions of vasopressin. In part 1 of the review we discuss structure, signaling pathways, and tissue distributions of the classic vasopressin receptors, namely V1 vascular, V2 renal, V3 pituitary and oxytocin receptors, and the P2 class of purinoreceptors. Knowledge of the function and distribution of vasopressin receptors is key to understanding the seemingly contradictory actions of vasopressin on the vascular system. In part 2 of the review we discuss the effects of vasopressin on vascular smooth muscle and the heart, and we summarize clinical studies of vasopressin in shock states.Keywords
This publication has 92 references indexed in Scilit:
- Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytesProceedings of the National Academy of Sciences of the United States of America, 2002
- Depletion of neurohypophyseal content of vasopressin in septic shock*Critical Care Medicine, 2002
- Chapter 14 Molecular pharmacology and modeling of vasopressin receptorsProgress in Brain Research, 2002
- Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatmentBritish Journal of Pharmacology, 2001
- Molecular Pharmacology of Human Vasopressin ReceptorsAdvances in experimental medicine and biology, 1998
- Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin ABritish Journal of Pharmacology, 1997
- Characterization of purified endosomes containing the antidiuretic hormone-sensitive water channel from rat renal papilla.Journal of Biological Chemistry, 1994
- Discovery, development, and some uses of vasopressin and oxytocin antagonists.1989
- Homologous regulation of human platelet vasopressin receptors does not occur in vivoAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1989
- Ventricular receptors stimulate vasopressin release during hemorrhageAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1988